跳至主要内容
临床试验/NCT04083625
NCT04083625已完成4 期

the Effect of Carbetocin in Decreasing Intraoperative Blood Loss in Abdominal Myomectomy: a Randomized Controlled Trial

Cairo University1 个研究点 分布在 1 个国家目标入组 138 人开始时间: 2019年9月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
138
试验地点
1
主要终点
Mean amount of intraoperative blood loss

研究概览

简要总结

To investigate the effectiveness of carbetocin on reducing intraoperative blood loss during abdominal myomectomy

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
25 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • • Patients presenting for abdominal myomectomy with documented uterine fibroids on pelvic imaging
  • Age ≥ 25 years and ≤ 50 years
  • Pre-operative hemoglobin >10 g/dl
  • Ability to understand and the willingness to sign a written informed consent.
  • Admissible medical/surgical history
  • Five or less symptomatic uterine myomas
  • symptomatic stage 3 to 6 fibroids, according to FIGO staging

排除标准

  • • Post-menopausal women
  • Patients with known bleeding/clotting disorders
  • Patients with a history of gynecologic malignancy
  • Hypertension.
  • Cardiac and Pulmonary diseases.
  • History of allergic reactions attributed to carbetocin

研究组 & 干预措施

carbetocin

Experimental

100microgram in 10 cm syringe carbetocin IV just before skin incision of myomectomy.

干预措施: carbetocin 100 mcg (Drug)

placebo

Placebo Comparator

10 cm syringe normal saline IV given just before skin incision of myomectomy.

干预措施: placebo (Drug)

结局指标

主要结局

Mean amount of intraoperative blood loss

时间窗: intraoperative

Mean amount of intraoperative blood loss in ml

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Samy aly ashour

assistant professor

Cairo University

研究点 (1)

Loading locations...

相似试验